Workflow
江苏硕世生物科技股份有限公司 2025年第三季度报告

Core Points - The company has announced changes in its registered capital and governance structure, including the cancellation of the supervisory board and amendments to its articles of association [7][8] - The company completed a share buyback program, resulting in a reduction of registered capital due to the cancellation of 1.949918 million shares [7] - Following a capital reserve conversion, the company's total share capital increased from 56.670082 million shares to 83.871721 million shares, with corresponding registered capital rising from RMB 56.670082 million to RMB 83.871721 million [7] Financial Data - The financial statements for the third quarter are unaudited, and the company has confirmed the accuracy and completeness of the financial information presented [3][4] - The company has not reported any non-recurring gains or losses for the current period [4] - The company has not experienced significant changes in major accounting data or financial indicators [5] Shareholder Information - The company has provided details on the total number of shareholders and the status of major shareholders, although specific figures are not disclosed in the announcement [6] Governance Changes - The company will no longer have a supervisory board, with the audit committee of the board taking over its responsibilities [8] - The company plans to comprehensively revise its articles of association and related governance documents to reflect these changes [8]